Skip to main content

Closed

MAIA: MAIA Biotechnology, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-88.9%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio5.59×

MAIA Biotechnology, Inc.

MAIANew York Stock Exchange Arca·USD·Closed

MAIA Biotechnology, Inc.

MAIANew York Stock Exchange Arca·USD·Closed

$1.40

+2.94%

$1.40

+$0.04 (2.94%)

52W Range

23thpctl

Volume

0.37×avg

Mkt Cap

85.12MUSD

P/E

-1.9TTM

Div Yield

–ann

52W Range

23thpctl

Volume

0.37×avg

Market Cap

85.12MUSD

P/E Ratio

-1.9TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings